Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy

NCT01737307 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-11-29

No results posted yet for this study

Summary

The purpose of this study was to investigate the effect of Fluoride varnish and Casein Phospho-Peptide Amorphous Calcium Phosphate (CPP-ACP) containing paste on oral symptoms and salivary characteristics in patients under chemotherapy.

Conditions

Interventions

DRUG

Fluoride varnish

Fluoride Varnish (NaF 5%)

OTHER

Oral Hygiene

Oral hygiene followed.

DRUG

CPP-ACP

CPP-ACP paste was applied by patient, once daily.

Sponsors & Collaborators

  • Azad University of Medical Sciences

    lead OTHER

Principal Investigators

  • Sepideh Banava, Assist-Prof · Azad University of Medical Sciences, Dental Branch

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-06-30
Completion
2011-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01737307 on ClinicalTrials.gov